Physicochemical Properties
| Molecular Formula | C19H18N2O3 |
| Molecular Weight | 322.364 |
| Exact Mass | 322.132 |
| Elemental Analysis | C, 70.79; H, 5.63; N, 8.69; O, 14.89 |
| CAS # | 133550-34-2 |
| Related CAS # | 133550-34-2 |
| PubChem CID | 5328770 |
| Appearance | Light yellow to yellow solid powder |
| Density | 1.273g/cm3 |
| Boiling Point | 621.1ºC at 760mmHg |
| Flash Point | 329.4ºC |
| Vapour Pressure | 5.09E-16mmHg at 25°C |
| Index of Refraction | 1.649 |
| LogP | 3.144 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Heavy Atom Count | 24 |
| Complexity | 488 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | O=C(/C(/C#N)=C(\[H])/C1C([H])=C([H])C(=C(C=1[H])O[H])O[H])N([H])C([H])([H])C([H])([H])C([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H] |
| InChi Key | GSQOBTOAOGXIFL-LFIBNONCSA-N |
| InChi Code | InChI=1S/C19H18N2O3/c20-13-16(11-15-8-9-17(22)18(23)12-15)19(24)21-10-4-7-14-5-2-1-3-6-14/h1-3,5-6,8-9,11-12,22-23H,4,7,10H2,(H,21,24)/b16-11+ |
| Chemical Name | (E)-2-cyano-3-(3,4-dihydroxyphenyl)-N-(3-phenylpropyl)prop-2-enamide |
| Synonyms | AG555; AG 555; AG-555 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | EGFR (IC50 = 0.7 μM) |
| ln Vitro |
AG 555 (100 μM) inhibits the virus's ability to integrate and synthesise viral proteins at both early and late stages of its life cycle[1]. Tyrphostins AG555 are very effective at stopping the growth of EGFR overexpressor cells because they block Cdk2 activation, which causes growth arrest of immortalized cells at G1-S and early S[2]. Tyrphostin AG 555 can bind phosphorylated Jun/ATF-2 at a novel intragenic regulatory sequence and activate the MAP kinase pathway to selectively suppress BPV-1 transcription[3]. |
| Cell Assay |
Cell Line: NIH/3T3 uninfected cells and NIH/3T3-Mo-MuLV chronically infected cells. Concentration: 100 μM. Incubation Time: 1 hour. Result: Inhibited Mo-MuLV proviral DNA integration. |
| References |
[1]. Tyrphostin AG-555 inhibits early and late stages of Moloney murine leukemia virus replication cycle. International Journal of Oncology. 1997. [2]. Tyrphostin AG494 blocks Cdk2 activation Nir Osherov. FEBS Letters 410 (1997) 187-190. [3]. Tyrphostin AG 555 Inhibits Bovine Papillomavirus Transcription by Changing the Ratio between E2 Transactivator/Repressor Function. Vol. 278, No. 39, Issue of September 26, pp. 37306–37313, 2003. |
| Additional Infomation | Tyrphostin B46 is a potent inhibitor of epidermal growth factor receptor kinase autophosphorylation. (NCI) |
Solubility Data
| Solubility (In Vitro) |
DMSO: ~64 mg/mL (~198.5 mM) Ethanol: ~64 mg/mL (~198.5 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (7.76 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (7.76 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.1021 mL | 15.5106 mL | 31.0212 mL | |
| 5 mM | 0.6204 mL | 3.1021 mL | 6.2042 mL | |
| 10 mM | 0.3102 mL | 1.5511 mL | 3.1021 mL |